20.500.12556/DiRROS-19838 Modern approach to the management of genitourinary syndrome in women with gynecological malignancies The term genitourinary syndrome of menopause was first used in 2014 by the North American Menopause Society and the International Society for the Study of Women's Sexual Health to describe conditions previously known as atrophic vaginitis, urogenital atrophy, or vulvovaginal atrophy. It is a complex, chronic, progressive condition characterized by a wide range of signs and symptoms affecting sexual function and the tissues of the urinary and genital tracts. The main cause of genitourinary syndrome of menopause is estrogen deficiency caused by ovarian removal or dysfunction. The most bothersome symptoms are vaginal dryness, decreased vaginal lubrication, and pain during penetration and intercourse. They all have a negative impact on the quality of life. Conclusions: The main goal of treatment is to relieve the symptoms. Treatment modalities are pharmacological or non-pharmacological. The first-line treatment for mild to moderate symptoms is the use of personal lubricants and moisturizers, but the gold standard is estrogen replacement therapy. Hormone therapy may not be an option for women with hormone-dependent cancer. genitourinary syndrome gynecological malignancies therapy genitalno-urinarni sindrom ginekološki raki onkološko zdravljenje true false true Association of Radiology and Oncology Ljubljana Angleški jezik Slovenski jezik by Authors Neznano 2024-07-25 14:24:27 2024-07-25 14:24:27 2024-07-29 03:34:18 0000-00-00 00:00:00 2023 0 0 str. 292-298 no. 3 Vol. 57 2023 0000-00-00 Zaloznikova Objavljeno NiDoloceno 0000-00-00 0000-00-00 2023-01-01 616.62-008.22 1318-2099 10.2478/raon-2023-0038 161056515 RAZ_Kovacevic_Nina_2023.pdf RAZ_Kovacevic_Nina_2023.pdf 1 82DDF96441AE26B6CF47D4DFE404E53E b5d397db7059b50ccbd580c7f3b88204872a8e231a942d3df57613af82615bb3 52f209af-4a70-11ef-b487-001a4af901a5 https://dirros.openscience.si/Dokument.php?lang=slv&id=27510 Onkološki inštitut Ljubljana 0 0 0